These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 36261902)
81. Jak-inhibitors and UV-B: Potential combined therapy for vitiligo. Urso B Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28833974 [No Abstract] [Full Text] [Related]
82. JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases. Kahn J; Deverapalli SC; Rosmarin D Semin Cutan Med Surg; 2018 Sep; 37(3):198-208. PubMed ID: 30215638 [TBL] [Abstract][Full Text] [Related]
83. Treatment responses in patients with vitiligo to very potent topical corticosteroids combined with vitaminotherapy in Madagascar. Sendrasoa FA; Ranaivo IM; Sata M; Andrianarison M; Raharolahy O; Rakotoarisaona MF; Razanakoto NH; Ramarozatovo LS; Rapelanoro Rabenja F Int J Dermatol; 2019 Aug; 58(8):908-911. PubMed ID: 31148154 [TBL] [Abstract][Full Text] [Related]
84. Effectiveness of 0.1% topical tacrolimus in adult and children patients with vitiligo. Udompataikul M; Boonsupthip P; Siriwattanagate R J Dermatol; 2011 Jun; 38(6):536-40. PubMed ID: 21352308 [TBL] [Abstract][Full Text] [Related]
85. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. Mikhail M; Wolchok J; Goldberg SM; Dunkel IJ; Roses DF; Silverberg NB Arch Dermatol; 2008 Apr; 144(4):560-1. PubMed ID: 18427063 [No Abstract] [Full Text] [Related]
86. Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream. Souza Leite RM; Craveiro Leite AA Int J Dermatol; 2007 Sep; 46(9):986-9. PubMed ID: 17822508 [TBL] [Abstract][Full Text] [Related]
87. Tacrolimus-induced hyperpigmentation in a patch of vitiligo. De D; Kanwar AJ Skinmed; 2008; 7(2):93-4. PubMed ID: 18327009 [TBL] [Abstract][Full Text] [Related]
88. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo. Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887 [TBL] [Abstract][Full Text] [Related]
95. Itch and Janus Kinase Inhibitors. Han Y; Woo YR; Cho SH; Lee JD; Kim HS Acta Derm Venereol; 2023 Feb; 103():adv00869. PubMed ID: 36789757 [TBL] [Abstract][Full Text] [Related]
96. Repigmentation of vitiligo macules treated topically with Efudix cream. Szekeres E; Morvay M Dermatologica; 1985; 171(1):55-9. PubMed ID: 4029463 [TBL] [Abstract][Full Text] [Related]
97. Fractional Er:YAG laser assisting topical betamethasone solution in combination with NB-UVB for resistant non-segmental vitiligo. Yan R; Yuan J; Chen H; Li YH; Wu Y; Gao XH; Chen HD Lasers Med Sci; 2017 Sep; 32(7):1571-1577. PubMed ID: 28710660 [TBL] [Abstract][Full Text] [Related]
98. Off-label Studies on the Use of Ruxolitinib in Dermatology. Tegtmeyer K; Ravi M; Zhao J; Maloney NJ; Lio PA Dermatitis; 2021 May-Jun 01; 32(3):164-172. PubMed ID: 33443378 [TBL] [Abstract][Full Text] [Related]
99. Topical tacrolimus for treatment of childhood vitiligo in Asians. Kanwar AJ; Dogra S; Parsad D Clin Exp Dermatol; 2004 Nov; 29(6):589-92. PubMed ID: 15550128 [TBL] [Abstract][Full Text] [Related]
100. Topical calcipotriol in childhood vitiligo: an Indian experience. Sarma N; Singh AK Int J Dermatol; 2004 Nov; 43(11):856-9. PubMed ID: 15533076 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]